Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06916130 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 8, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.
Trial Details
NCT Number NCT06916130
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Gastroesophageal Reflux Disease (GERD)
Related terms Gastroesophageal Reflux
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov